Potential of dyes as draw solutions in forward osmosis for the south african textile industry

The textile industry produces large volumes of wastewater that requires appropriate treatment before being released into the environment. Research globally has focused on advanced desalination technologies to augment the limited freshwater resources. Forward osmosis (FO) technology has gained substantial interest as a possible lower-energy desalination technology. However, challenges such as the availability of effective draw solutions (DS) have limited its implementation. This study evaluated alternative feed water resources and assessed the potential of dye solutions as DS. The aim is to dilute a concentrated dye DS to a target concentration for direct dye-batch use, thereby reclaiming water resources. The measured osmotic pressure (OP) of the alternative feed solutions (synthetic brackish water; syntethic seawater; seawater from the Atlantic and Indian Oceans; and wastewater from two textile factories) were 414, 2 761, 2 580, 2 614; 1 716 and 7 822 kPa, respectively. Three basic dyes (Maxilon Turquoise, Red and Blue) and three reactive dyes (Carmine, Olive Green and Black) were selected based on common use in the South African textile industry. The dye samples were prepared without and with lt at different concentrations and different dye-to-salt mass ratios ranging from 1:10 to 1:60. The OP trends for the basic dyes followed Blue >> Red > Turquoise and for the reactive dyes Black >> Olive > Carmine. The overall OP trend was Black > Olive > Carmine > Blue > Red > Turquoise. The OP at different dye concentrations and different dye-to-salt ratios was mostly influenced by the dye chemistry and molecular weight (Mw) rather than the type of dye, i.e., reactive vs basic.The OP trend for the dye-to-salt ratios was 1:60 > 1:50 > 1:40 > 1:30 > 1:20 > 1:10. For both the basic and reactive dyes a linear relationship exists between OP and dye concentration; as well as between OP and Mw. The dye DS exhibited larger OP compared to that of the FS evaluated, thus rendering them suitable DS

Efficacy of natural antimicrobials in toothpaste formulations against oral biofilms in vitro

AbstractObjectivesTo evaluate the antimicrobial efficacies of two toothpaste formulations containing natural antimicrobials (herbal extracts and chitosan) against oral biofilms of different composition and maturational status.MethodsBacteria from a buffer suspension or fresh saliva were adhered for 2h to a salivary conditioning film and subsequently grown for 16h. Dual-species biofilms were prepared from Actinomyces naeslundii T14V-J1 and Streptococcus oralis J22, whilst multi-species biofilms were grown from freshly collected human saliva. Biofilms were exposed to 25wt% toothpaste supernatants. A chlorhexidine-containing mouthrinse and a buffer were used as positive- and negative-controls, respectively. Antibacterial efficacy was concluded from acute killing, bacterial removal, prevention of bacterial re-deposition and continued killing during re-deposition.ResultsThe herbal- and chitosan-based supernatants showed immediate killing of oral biofilm bacteria, comparable with chlorhexidine. Moreover, exposure of a biofilm to these supernatants or chlorhexidine, yielded ongoing killing of biofilm bacteria after exposure during re-deposition of bacteria to a matured 16h biofilm, but not to a much thinner initial biofilm formed by 2h adhesion only. This suggests that thicker, more matured biofilms can absorb and release oral antimicrobials.ConclusionsSupernatants based on herbal- and chitosan-based toothpastes have comparable immediate and ongoing antibacterial efficacies as chlorhexidine. Natural antimicrobials and chlorhexidine absorb in oral biofilms which contributes to their substantive action

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

Streptomyces coelicolor biofilm growth kinetics and oxygen mass transfer within a membrane gradostat bioreactor

Thesis (MTech (Chemical Engineering))--Cape Peninsula University of Technology, 2009The main purpose of this study was to quantify the growth and oxygen mass transfer kinetic parameters of the filamentous bacterium Streptomyces coelicolor, immobilised on the external surface of a ceramic membrane in a continuously operated pressurised Membrane Gradostat Bioreactor (MGR). One of the most important and critical parameters required when studying biofilms, are the growth kinetics, as they can be utilised to model both the mass transfer and biological reactions occurring within the biofilm. Single fibre MGR's (SFMGR) were operated using a pneumatic system to supply humidified pressurised air to the extra capillary space (ECS) and pressurised growth medium to the lumen of the ceramic membrane. Two growth media; a complex growth medium, ISP2, and a defined growth medium, were tested and supplied to the lumen of the ceramic membrane in the dead-end mod

Membrane bioreactor application within the South African textile industry: pilot to full-scale

Thesis submitted in the requirements for the degree Doctor Technologiae: Chemical Engineering in the Faculty of Engineering at the CAPE PENINSULA UNIVERSITY OF TECHNOLOGY, 2013To date, limited information has been published on textile wastewater treatment, for re-use, in South Africa (SA), with treatment processes focusing on conventional wastewater treatment methods. A large contributor to the contamination of water within textile industries is from dyehouse processes. A major concern in textile wastewater treatment is the release of azo dyes and their metabolites, some of which are carcinogenic and mutanogenic, into the environment since they are xenobiotic and aerobically recalcitrant to biodegradation. A necessity therefore exists to find an effective treatment method capable of removing both the strong colour and the toxic organic compounds from textile wastewater. Membrane bioreactors (MBRs) are favoured when treating high-strength wastewater, since the membrane area is determined by the hydraulic throughput and not the biological load; no sludge is wasted and all bacteria are retained within the reactor, including specific bacteria capable of degrading the toxic, non-biodegradable constituents present in textile wastewater. MBR systems, using various configurations have been utilised extensively in the rest of the world to treat textile wastewater at both lab and pilot-scale. This DTech project formed part of a collaborative Water Research Commission (WRC) funded project K5/1900 - Pilot application of a dual-stage membrane bioreactor (dsMBR) for industrial wastewater treatment. The main purpose of this study was the on-site evaluation of a pilot-scale dsMBR incorporating two ultrafiltration (UF) sidestream membrane modules for the treatment, recovery and re-use of textile wastewater. The objectives of this project were to determine the treatment efficiency of the system; to evaluate the degree of colour removal from the textile wastewater; to improve residual colour removal within the system using treatment processes, such as NF and RO, as well as to propose a design and cost for a full-scale plant. A textile industry located in Bellville, Western Cape, was chosen as the industrial partner for the on-site evaluation of a semi-automated pilot wastewater treatment MBR plant using two 5.1 m2 Norit X-flow AirliftTM membrane modules. Since the wastewater treatment system was located on the premises, real continuously changing industrial wastewater was being treated. The industrial textile wastewater was treated in a series of tanks: 1) an anaerobic tank, which cleaved the azo bonds of the reactive dyes; 2) an anoxic tank containing reduced amounts of dissolved oxygen, in which denitrification occurred; and 3) an aerobic tank, in which i) nitrification, as well as ii) mineralisation of the aromatic amines occurred. The UF-membrane modules would account for the removal of any organic material. The wastewater stream was characterised by a chemical oxygen demand (COD) range of between 45 to 2,820 mg/L and an average biological oxygen demand (BOD) of 192.5 mg/L. The dsMBR achieved an average COD reduction of 75% with a maximum of 97% over the 220 day test period. The COD concentration obtained after dsMBR treatment averaged at 191 mg/L, which was well within the City of Cape Town industrial wastewater discharge standard. The average reduction in turbidity and TSS was 94% and 19.6%, respectively, during the UF-MBR stage of the system. Subsequent treatment of the UF permeate with nanofiltration (NF) for 4 days, alternated with reverse osmosis (RO) for 14 days removed both the residual colour and salt present in the UF permeate. A consistent reduction in the colour of the incoming wastewater was evident. The colour in the wastewater was reduced from an average of 659 ADMI units to ~12 ADMI units in the NF permeate, a lower American dye manufacturing index (ADMI) (i.e. method of colour representation) compared to the potable water (~17 ADMI units) utilised by the industrial partner in their dyeing processes. The colour was reduced from an average of 659 to ~20 ADMI units in the RO permeate, a lower ADMI and therefore colour when compared to the potable water. An average conductivity rejection of 91% was achieved with conductivity being reduced from an average of 7,700 to 693 μS/cm and the TDS reduced from an average of 5,700 to 473 mg/L, which facilitated an average TDS rejection of 92%. Based on the composition of the UF permeate fed to the RO membrane a maximum removal of 98.7% was achieved for both conductivity and total dissolved solids (TDS). The proposed full-scale plant would incorporate a UF-MBR system, followed by NF, RO, flocculation and a filter press. Therefore, the two waste products produced during operation of the proposed full-scale plant, would be the solid filter cakes and the liquid filtrate from the filter press. Implementing the proposed full-scale plant it would cost the industrial partner an operating cost of ZAR 113.85 and ZAR 3,415.49 to treat 97.1 m3 and 2,913 m3 of textile wastewater, respectively, per day and per month. This results in an annual saving of ZAR 845,848 on potable water expenses. This research, would provide SA textile industries, with an option to: 1) reduce their water consumption, thereby utilising less of a valuable decreasing commodity; 2) meet the SA government discharge standards and reduce their discharge costs; 3) reduce their carbon footprint (i.e. reduce their impact on the environment) by re-using their treated wastewater and therefore using less water from the municipality; and 4) decrease their annual expenditure on water, since the treated wastewater would be available for re-use

A Pilot study of Google's PageRank ranking algorithm and its effect on the placement of webpages in search engine results

The principal objective of this research project was to study Google PageRank's methodology and its results as perceived by the user. Neither the effect of the PageRank algorithm nor details of other factors influencing ranking are clear. The results will hopefully act as a guide for Google's users and customers submitting their pages for further ranking. The methods employed in this research project were to identity and study the factors used by Google to determine a webpage's ranking. The PageRank algorithm was identified and defined in as much detail as was made available and the impact on the final Google ranking was discussed. Other aspects discussed included the following: the impact of keywords and other design factors variations in the PageRank algorithm and the impact of attempted results manipulations. The results prove that Google's PageRank is based on a system of rating relevancy by calculating the number of links to the queried page. It is also known that PageRank is not the only algorithm used by Google and that on page factors also help to determine the final page ranking. The conclusion reached is that Google's methodology used to rank webpageis superior to those of their competition and that Google's continued popularity is based on innovation and expansion

Colour removal from textile wastewater using a pilot-scale dual-stage MBR and subsequent RO system

A necessity exists to find an effective treatment method capable of removing both the strong colour and the toxic organic compounds from textile wastewater. A pilot-scale dual-stage membrane bioreactor (dsMBR) incorporating two ultrafiltration (UF) sidestream membrane modules was designed, constructed, operated and evaluated on-site for treating high strength textile wastewater. The wastewater stream was characterised by a colour range of 195–2070 ADMI units and a chemical oxygen demand (COD) of between 728 and 1033 mg/L. A consistent reduction in the colour of the incoming wastewater was evident in the treatment stages. The residual colour and remaining salt in the UF permeate was treated with reverse osmosis (RO). The colour in the wastewater was reduced from an average of 660 ADMI units to 12 ADMI units in the RO permeate, a lower ADMI compared to the potable water (17 ADMI units) used on-site by this textile company

Membrane bioreactor application within the treatment of high strength textile effluent

A pilot-scale dual-stage membrane bioreactor (dsMBR) incorporating two ultra-filtration (UF) side-stream membrane modules was designed, constructed, operated and evaluated on-site for treating high-strength textile effluent. The effluent stream was characterised by a COD range of between 45 to 2,820 mg/L and an average BOD of 192.5 mg/L. The dsMBR achieved an average COD reduction of 75% with a maximum of 97% over the 9 month test period. The COD concentration obtained after dsMBR treatment averaged at 190 mg/L, which was well within the discharge standard. The average reduction in turbidity and TSS were 94% and 19.6%, respectively, during the UF-MBR stage of the system. Subsequent treatment of the UF-permeate with nanofiltration (NF) and reverse osmosis (RO) removed both the residual colour and remaining salt. A consistent reduction in the color of the incoming effluent was evident. The ADMI was reduced from an average of 659 to ∼20, a lower ADMI and colour compared to the potable water. An average conductivity rejection of 91% was achieved with conductivity being reduced from an average of 7,700 to 693 μS/cm and the TDS reduced from an average of 5,700 to 473 mg/L, which facilitated an average TDS rejection of 92%

Modelling growth kinetics of Streptomyces coelicolor A3(2) in a pressurised membrane gradostat reactor (MGR)

de Jager, D., Sheldon, M. S., & Edwards, W. (2009). Modelling growth kinetics of Streptomyces coelicolor A3 (2) in a pressurised membrane gradostat reactor (MGR). Enzyme and Microbial Technology, 45(6), 449-456. DOI: http://dx.doi.org/ 10.1016/j.enzmictec.2009.08.010Limited information is available with regards to the microbial growth kinetics of Streptomyces coelicolor A3(2) immobilised in pressurised membrane gradostat reactors (MGR). The purpose of this study was to quantify the growth kinetics of the filamentous bacterium immobilised on the external surface of ceramic membranes. The single fibre MGR's (SFMGR) were operated using a pneumatic system to supply humidified pressurised air to the extra capillary space (ECS). The nutrient growth medium was supplied to the lumen of the ceramic membrane in the dead-end mode. The growth curve that was obtained for S. coelicolor A3(2) showed the presence of two growth cycles (biphasic growth) from ±66 to 162 h and ±162 to 354 h, respectively, with no noticeable intermediate lag phase. A faster specific growth rate of 0.049 h−1 was obtained for the first growth cycle, with a lower specific growth rate in the range of ±0.013 to 0.019 h−1 obtained for the second growth cycle. The growth kinetics of S. coelicolor A3(2) within a pressurised MGR has not been reported previously